Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/1997
10/09/1997CA2249349A1 Design of novel highly efficient hiv based packaging systems for gene therapy
10/08/1997EP0799893A1 Defective viral particles obtained in vivo or ex vivo as vaccine
10/08/1997EP0799873A1 Composition for a non-wettable coating, process for treating glazing pane with this composition and the products obtained
10/08/1997CN1161715A DNA encoding ovine adenovirus (OAV 287) and its use as a viral vector
10/08/1997CN1161375A Colon bacillus cytosine ammonialyase gene and a new substance containing same
10/07/1997US5674835 Papillomaviral expression inhibitors
10/07/1997US5674729 From lysate of mammalian cells from which nuclei and mitochondria have been removed
10/07/1997US5674537 Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species
10/07/1997US5674500 Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus mutants
10/07/1997US5674499 Equine herpesvirus gene 15 mutants
10/07/1997US5674485 Insect diagnostic and control compositions with truncated JHE
10/07/1997US5674484 Vaccine antigens for treatment of poultry
10/02/1997WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997WO1997035996A1 Packaging cell line based on human 293 cells
10/02/1997WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997DE19612967A1 Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren Method for replication of influenza viruses in cell culture, as well as the influenza viruses obtainable by the process
10/02/1997DE19612966A1 Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren Animal cells and processes for replication of influenza viruses
10/02/1997CA2250452A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997CA2250173A1 Cytochrome p450 transducing retroviral vectors
10/02/1997CA2250058A1 Recombinant pox virus encoding myelin protein for therapy
10/01/1997EP0798003A2 Use of structured depth filters for virus removal
10/01/1997EP0797680A1 Methods, compositions and apparatus for cell transfection
10/01/1997EP0797679A2 Recombinant alphavirus vectors
10/01/1997EP0797678A2 Hybrid adenovirus-aav virus and method of use thereof
10/01/1997EP0797677A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons
10/01/1997EP0797676A2 Recombinant adenoviral vector and methods of use
10/01/1997EP0797660A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants
10/01/1997EP0797455A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c
10/01/1997EP0797454A1 Improved adenoviral vectors and producer cells
10/01/1997EP0797445A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents
10/01/1997EP0797436A1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
10/01/1997EP0648272B1 Protein based delivery system
09/1997
09/30/1997US5672485 Immortalized cell lines for virus growth
09/30/1997US5672344 Viral-mediated gene transfer system
09/30/1997CA2055463C Antiviral therapy using thiazine and xanthene dyes
09/25/1997WO1997035008A1 Methods and compositions of chimeric polypeptides for tumor antigen vaccines
09/25/1997WO1997022363A3 Improved pharmaceutical compositions
09/24/1997EP0796331A2 Production and administration of high titer recombinant retroviruses
09/24/1997EP0796094A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light
09/24/1997CN1160420A Pesticidal proteins and strains
09/24/1997CN1160345A Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
09/23/1997US5670630 Expression of hepatitis B S and preS2 proteins in methylotrophic
09/23/1997US5670367 Recombinant fowlpox virus
09/23/1997US5670354 Use of VSV-G pseudotyped vectors for transfer of genes into embryos
09/23/1997CA1339468C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
09/18/1997WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy
09/18/1997WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
09/18/1997WO1997033975A1 Medium for preserving biological materials
09/18/1997WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
09/18/1997CA2248978A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
09/18/1997CA2248612A1 Recombinant adenoviral vectors for human tumour gene therapy
09/18/1997CA2248200A1 Medium for preserving biological materials
09/17/1997EP0795021A2 Retroviral delivery of full length factor viii
09/17/1997CN1159480A Monobleb viras currier capable of being used in packaging recombination of adenovirus concomitant virus and use thereof
09/16/1997US5668005 Cloned genes encoding reverse transcriptase lacking RNASE H activity
09/12/1997WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
09/12/1997WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells
09/12/1997WO1997032983A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines
09/12/1997WO1997032481A1 Helper-free, totally defective adenovirus for gene therapy
09/12/1997WO1997021826A3 Complementary adenoviral vector systems and cell lines
09/12/1997WO1997017457A3 Stable packaging cell line producing pseudotyped retroviruses
09/12/1997CA2247806A1 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
09/12/1997CA2247091A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines
09/11/1997DE19608751A1 Adeno-assoziierter Virus-Vektor zur Steigerung der Immunogenität von Zellen Adeno-associated virus vector for enhancing the immunogenicity of cells
09/10/1997EP0794257A1 Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino aced sequence and vaccine containing same
09/10/1997EP0793970A1 Photodynamic inactivation of viruses
09/10/1997EP0793728A1 Expression of the bovine parainfluenza virus type 3 hemagglutinin/neuraminidase (hn) glycoprotein in two heterologous systems
09/10/1997CN1159210A Non self-inactivating, Expression targeted retroviral vectors
09/10/1997CN1159209A Recombinant herpesvirus with the use of gB Gene promoter
09/10/1997CN1159143A Insect control method with genetically engineered biopesticides
09/10/1997CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
09/09/1997US5665592 Feline immunodeficiency virus isolate NCSU1
09/09/1997US5665534 Method of detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
09/09/1997US5665357 Antibodies recognizing tumor associated antigen CA 55.1
09/09/1997US5665349 Recombinant baculovirus with insecticidal activity
09/08/1997CA2196736A1 Photodynamic inactivation of viruses
09/04/1997WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines
09/04/1997WO1997032018A2 Hepatitis c virus ribozymes
09/04/1997WO1997032010A1 Method of purifying and removing viruses
09/04/1997WO1997031651A1 Porcine reproductive and respiratory syndrome vaccine
09/04/1997WO1997021824A3 Method for obtaining retroviral vector supernatant having high transduction efficiency
09/04/1997DE19639601A1 Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen Parapox virus containing the foreign DNA, their preparation and their use in vaccines
09/03/1997EP0792363A1 Novel pesticidal proteins and strains
09/03/1997EP0792169A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors
09/03/1997EP0484374B1 Rapid, versatile and simple system for expressing genes in eukaryotic cells
09/02/1997US5663069 Modified lambda bacteriophage
09/02/1997US5663043 Method for inactivating non-enveloped viruses using a viricide-potentiating agent with a photoactivatible virucide
09/02/1997US5662897 Isolated and purified recombinant autographa californica nuclear polyhedrosis virus
09/02/1997US5662896 Directly administering a vector construct which directs the expression of antitumor agents
08/1997
08/28/1997WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization
08/28/1997WO1997030732A1 Liposomal-viral dna complexes for treating disease
08/28/1997WO1997020935A3 Viral vectors
08/28/1997WO1997020051A3 Vectors and methods for gene transfer to cells
08/28/1997CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization
08/28/1997CA2241142A1 Liposomal-viral dna complexes for treating disease
08/27/1997EP0791055A1 Method for producing biologicals in protein-free culture
08/27/1997EP0790836A1 Serially passaged african green monkey kidney cells